Cas:1289387-90-1 3-iodopiperidine manufacturer & supplier

We serve Chemical Name:3-iodopiperidine CAS:1289387-90-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-iodopiperidine

Chemical Name:3-iodopiperidine
CAS.NO:1289387-90-1
Synonyms:i12-0647;ht989
Molecular Formula:C5H10IN
Molecular Weight:211.04400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.03000
Exact Mass:210.98600
LogP:1.50220

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like i12-0647 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ht989 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,i12-0647 Use and application,i12-0647 technical grade,usp/ep/jp grade.


Related News: In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. 4-cyanobenzyl 4-cyano-5-[(2-ethylbutanoyl)amino]-3-methylthiophene-2-carboxylate manufacturers With rising demand and approvals required for new drugs, an external collaboration with CDMOs helps in driving a successful and robust clinical development plan for a new drug molecule. Herbadysidolid suppliers Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY. Synthase, pyrroline-5-carboxylate (Arabidopsis thaliana strainColumbia clone pQB3 gene P5CS2 isoenzyme) vendor & factory “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement.,In addition, the government has made a series of new commitments, including: